Proferrin
Proferrin, licence 02247909: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Colorado Biolabs Inc.
- NPN or DIN-HM
- 02247909
- Status
- Active licence
- Licence date
- 9 November 2007
- Revision date
- 9 August 2018
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
- Dose déclarée au-delà d'une limite
Fer: up to 33 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 14 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Fer Source : Heme iron polypeptide | 11.0 mg | 33,000 µg |
| Fer Source : Hémoglobine bovine | 11.0 mg | 33,000 µg |
Non-medicinal ingredients
Dioxyde de silicium, FD&C Blue No.2 Aluminum Lake, Talc, Cellulose, microcristalline, Croscarmellose de sodium, FD & C Yellow #5 Aluminium Lake, Dioxyde de titane, Stéarate de calcium, Poly(alcool vinylique), Povidone, Poly(éthylène glycol)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Comprimé | minimum: 1.0 Tous les jours ; maximum: 3.0 Tous les jours |
Uses authorised in Canada
Used to prevent or treat those at risk of iron deficiency (anemia).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Before using heme iron polypeptide individuals should tell their pharmacist or doctor if using methydopa or other iron-containing products. Iron supplements can decrease the absorption of drugs such as tetracycline antibiotics, penicillamine, cefdinir, chloramphenicol, levothryoxine, levodopa and quinolone antibiotics. Therefore, doses of these medications should be spaced as far as possible. This product may interfere with certain laboratory tests (including testing for blood in stool) possible causing false test results. Make sure laboratory personnel and all doctors know a patient is using this drug. This product should not be used if you have certain medical conditions. Individuals that have hemochromatosis, other types of anemia, repeated blood transfusions, or stomach/intestinal problems should tell their pharmacist or doctor before using this product.
Source
Official Health Canada record, licence 02247909
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.